Zura Bio Ltd (ZURA) has a current Price-to-Book (P/B) ratio of 3.33. Compared to its 3-year average P/B ratio of 2.53, the current P/B ratio is approximately 31.76% higher. Relative to its 5-year average P/B ratio of -0.08, the current P/B ratio is about -4092.31% higher. Zura Bio Ltd (ZURA) has a Forward Free Cash Flow (FCF) yield of approximately -14.83%. Compared to its 3-year average FCF yield of -15.21%, the current FCF yield is approximately -2.52% lower. Relative to its 5-year average FCF yield of -15.21%, the current FCF yield is about -2.52% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for ZURA competitors is 19759.45, providing a benchmark for relative valuation. Zura Bio Ltd Corp (ZURA.O) exhibits a P/S ratio of 0.00, which is -100% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of ZURA increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of ZURA in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is ZURA currently overvalued or undervalued?

What is Zura Bio Ltd (ZURA) fair value?

ZURA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Zura Bio Ltd (ZURA) is between to according to relative valuation method.

How does ZURA's valuation metrics compare to the industry average?

The average P/S ratio for ZURA's competitors is 19759.45, providing a benchmark for relative valuation. Zura Bio Ltd Corp (ZURA) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

What is the current P/B ratio for Zura Bio Ltd (ZURA) as of Mar 03 2026?

As of Mar 03 2026, Zura Bio Ltd (ZURA) has a P/B ratio of 3.33. This indicates that the market values ZURA at 3.33 times its book value.

What is the current FCF Yield for Zura Bio Ltd (ZURA) as of Mar 03 2026?

As of Mar 03 2026, Zura Bio Ltd (ZURA) has a FCF Yield of -14.83%. This means that for every dollar of Zura Bio Ltd's market capitalization, the company generates -14.83 cents in free cash flow.

What is the current Forward P/E ratio for Zura Bio Ltd (ZURA) as of Mar 03 2026?

As of Mar 03 2026, Zura Bio Ltd (ZURA) has a Forward P/E ratio of -7.17. This means the market is willing to pay $-7.17 for every dollar of Zura Bio Ltd's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Zura Bio Ltd (ZURA) as of Mar 03 2026?

As of Mar 03 2026, Zura Bio Ltd (ZURA) has a Forward P/S ratio of 0.00. This means the market is valuing ZURA at $0.00 for every dollar of expected revenue over the next 12 months.

ZURA Valuation